Clinical Trial Update: Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lidocaine patch 5% to celecoxib 200 mg for chronic axial low back pain; the study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Celecoxib 200 mg (celecoxib)
• Lidocaine patch 5% (Lidocaine)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Chronic Low Back Pain | Phase 4 | Status: TERMINATED